Replies to post #204124 on NorthWest Biotherapeutics Inc (NWBO)

[john1045]

Very interesting connection here! Great find and thanks for sharing.

Here is the PR on Sir Bruce Keogh

https://www.businesswire.com/news/home/20180531005874/en/Petrichor-Names-National-Medical-Director-National-Health

May 31, 2018 10:37 AM Eastern Daylight Time
NEW YORK--(BUSINESS WIRE)--Petrichor Healthcare Capital Management (“Petrichor”), a healthcare investment firm, today announced the appointment of Sir Bruce Keogh to its newly-formed Advisory Board. Throughout Sir Bruce’s exceptional career in the healthcare industry he has held multiple senior positions across the public and private sectors, as well as in academia. His experience includes over a decade of service as Medical Director of National Health Service (NHS) England, the organization responsible for the provision of healthcare services throughout the UK. Prior to his role at the NHS, Sir Bruce had a distinguished international career as a practicing cardiac surgeon.

“There is tremendous value in the breadth of Petrichor’s expertise in healthcare and finance, and I look forward to working with them in an advisory capacity and supporting their investments in leading healthcare companies.”

“I have worked closely with members of the Petrichor team and am impressed with their capabilities,” Sir Bruce said. “There is tremendous value in the breadth of Petrichor’s expertise in healthcare and finance, and I look forward to working with them in an advisory capacity and supporting their investments in leading healthcare companies.”

Petrichor Founder and Managing Partner Tadd S. Wessel welcomed Sir Bruce’s support, saying, “Sir Bruce has unparalleled expertise in setting healthcare policy, and his experience places him at the forefront of the industry’s evolution. Sir Bruce brings a wealth of experience analyzing and delivering new treatment paradigms with a value-based mindset. We are excited to have him join us in this new role at Petrichor.”

Message in reply to:

Cryoport may be behind the UK Property Transaction. Today they announced a significant financing from Petrichor Healthcare Capital Management.

https://www.prnewswire.com/news-releases/cryoport-announces-25-million-investment-from-petrichor-healthcare-capital-management-300767257.html

Cryoport provides cryogenic logistic services for Novartis and Gilead for their CAR-T therapies, and has logistics depots next to both of their manufacturing facilities. Cryoport provided logistics services for Northwest Biotherapeutics during their trial and would require a significant amount of warehouse space for commercial production, and would begin preparations well in advance. As I noted on a post on the CYRX board, “Sir Bruce Keogh, is a member of Petrichor's Advisory Board and recent appointee to the Board of Directors of UK-based non-profit Cell and Gene Therapy (CGT) Catapult.”

https://petrichorcap.com
What We Do
Petrichor makes structured equity and credit investments across the global healthcare sector, with a focus on Biopharmaceuticals, Medical Technology, and Diagnostics. We provide flexible and tailored investment solutions for late and commercial stage companies. We work with both public and private companies to support their long-term growth efforts and have experience underwriting product acquisitions, product development activities, and commercial launches or expansions, among other types of situations. Our investment structures are designed to provide capital solutions that enable leading healthcare innovators to reach the next stage of their evolution. Petrichor acts as a strategic advisor, partnering with management, Boards of Directors, and other investors to help ensure the success of our companies.

[XenaLives]

Or possibly Petrichor is the investor, creating a healthcare "park"?